临床试验/NCT01260285

NCT01260285已完成1 期

The Safety of Vardenafil in Patients Undergoing Cardiac Surgery

McGuire Research Institute1 个研究点分布在 1 个国家目标入组 10 人开始时间: 2010年12月最近更新: 2011年11月4日

适应症

干预措施

相关药物

试验速览

阶段: 1 期
状态: 已完成
发起方
入组人数: 10
试验地点: 1
主要终点: Hypotension

研究概览研究设计入排标准研究组 & 干预措施结局指标研究者研究点记录与标识符相似试验

研究概览

简要总结

The purpose of this study is to evaluate the safety of vardenafil in cardiac surgery patients.

研究设计

研究类型: Interventional
分配方式: Non Randomized
干预模型: Single Group
主要目的: Treatment
盲法: None

入排标准

年龄范围: 18 Years 至 90 Years（Adult, Older Adult）
性别: All
接受健康志愿者: 否

入选标准

•undergoing cardiac surgery

排除标准

•emergent surgery
•recent MI in past 7 days prior to surgery
•ejection fraction < 35%
•creatinine > 2.0
•prior CVA
•severe COPD
•recent use of nitrates (within past 48 hours prior to surgery)
•prior CABG
•pregnancy

研究组 & 干预措施

Vardenafil

Experimental

干预措施: Vardenafil (Drug)

结局指标

主要结局

Hypotension

时间窗: approximately 5 days

次要结局

Ejection Fraction(approximately 5-7 days postop)

研究者

发起方

McGuire Research Institute

申办方类型

Other

研究点 (1)

Loading locations...

相似试验

Cardiovascular Safety Study of Lodenafil Carbonate in Patients With Coronaropathy During Physical EffortCoronaropathyErectile Dysfunction

NCT00817830Cristália Produtos Químicos Farmacêuticos Ltda.

A Study To Assess If 10 mg Vardenafil (BAY38-9456) Taken Twice Daily For 6 Weeks Has An Effect On Bladder FunctionDetrusor OveractivityOveractive Bladder

NCT00478881Bayer397

Sildenafil Impact on Ventricular Function in Patients With Heart FailureHeart Failure

NCT01936350Hospital Ana Nery24

Evaluation of Sildenafil for the Treatment of Moderate Congestive Heart FailureHeart Failure

NCT00793338University of New Mexico

Vardenafil in TinnitusTinnitus

NCT00666809Bayer43